253 related articles for article (PubMed ID: 22152691)
1. [Expression of CD82/KAI1 and HIF-1α in non-small cell lung cancer and their relationship to vasculogenic mimicry].
Wu S; Cheng Z; Yu L; Song W; Tao Y
Zhongguo Fei Ai Za Zhi; 2011 Dec; 14(12):918-25. PubMed ID: 22152691
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the correlation of vasculogenic mimicry, Notch4, DLL4, and KAI1/CD82 in the prediction of metastasis and prognosis in non-small cell lung cancer.
Wang Y; Yang R; Wang X; Ci H; Zhou L; Zhu B; Wu S; Wang D
Medicine (Baltimore); 2018 Dec; 97(52):e13817. PubMed ID: 30593175
[TBL] [Abstract][Full Text] [Related]
3. Expression and clinical significance of CD82/KAI1 and E-cadherin in non-small cell lung cancer.
Shiwu WU; Lan Y; Wenqing S; Lei Z; Yisheng T
Arch Iran Med; 2012 Nov; 15(11):707-12. PubMed ID: 23102249
[TBL] [Abstract][Full Text] [Related]
4. Expressions of KAI1 and E-cadherin in nonsmall cell lung cancer and their correlation with vasculogenic mimicry.
Ci H; Xu Z; Xu J; Wang Y; Wu S
Medicine (Baltimore); 2018 Oct; 97(40):e12293. PubMed ID: 30290593
[TBL] [Abstract][Full Text] [Related]
5. [Expression of Gal-3 and CD82/KAI1 proteins in non-small cell lung cancer and their clinical significance].
Wu SW; Yu L; Zhou L; Cheng ZN; Tao YS
Zhonghua Zhong Liu Za Zhi; 2013 Feb; 35(2):124-8. PubMed ID: 23714667
[TBL] [Abstract][Full Text] [Related]
6. Aberrant expression of CD133 in non-small cell lung cancer and its relationship to vasculogenic mimicry.
Wu S; Yu L; Wang D; Zhou L; Cheng Z; Chai D; Ma L; Tao Y
BMC Cancer; 2012 Nov; 12():535. PubMed ID: 23170850
[TBL] [Abstract][Full Text] [Related]
7. KAI1/CD82 expression in nonsmall cell lung carcinoma is a novel, favorable prognostic factor: an immunohistochemical analysis.
Higashiyama M; Kodama K; Yokouchi H; Takami K; Adachi M; Taki T; Ishiguro S; Nakamori S; Yoshie O; Miyake M
Cancer; 1998 Aug; 83(3):466-74. PubMed ID: 9690539
[TBL] [Abstract][Full Text] [Related]
8. Expression of maspin in non-small cell lung cancer and its relationship to vasculogenic mimicry.
Wu S; Yu L; Cheng Z; Song W; Zhou L; Tao Y
J Huazhong Univ Sci Technolog Med Sci; 2012 Jun; 32(3):346-352. PubMed ID: 22684556
[TBL] [Abstract][Full Text] [Related]
9. Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer.
Adachi M; Taki T; Ieki Y; Huang CL; Higashiyama M; Miyake M
Cancer Res; 1996 Apr; 56(8):1751-5. PubMed ID: 8620488
[TBL] [Abstract][Full Text] [Related]
10. [Correlation between bacterial L-form infection, expression of HIF-1α/MMP-9 and vasculogenic mimicry in epithelial ovarian cancer].
Yu L; Wu SW; Zhou L; Song WQ
Sheng Li Xue Bao; 2012 Dec; 64(6):657-65. PubMed ID: 23258329
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the correlation of vasculogenic mimicry, ALDH1, KAI1 and microvessel density in the prediction of metastasis and prognosis in colorectal carcinoma.
Zhu B; Zhou L; Yu L; Wu S; Song W; Gong X; Wang D
BMC Surg; 2017 Apr; 17(1):47. PubMed ID: 28431527
[TBL] [Abstract][Full Text] [Related]
12. [Expressions of CD133 and CD82/KAI1 in bladder urothelial carcinoma and their correlation with vasculogenic mimicry].
Yu L; Wu S; Zhou L; Song W; Wang D
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Sep; 33(9):1336-40. PubMed ID: 24067216
[TBL] [Abstract][Full Text] [Related]
13. KAI1/CD82, Metastasis Suppressor Gene as a Therapeutic Target for Non-Small-Cell Lung Carcinoma.
Prabhu VV; Devaraj SN
J Environ Pathol Toxicol Oncol; 2017; 36(3):269-275. PubMed ID: 29283339
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological significance of cancer stem cells marked by CD133 and KAI1/CD82 expression in laryngeal squamous cell carcinoma.
Yu L; Zhou L; Wu S; Gong X; Feng Z; Ma L; Zhu B; Yao N; Wang D; Dong H
World J Surg Oncol; 2014 Apr; 12():118. PubMed ID: 24758564
[TBL] [Abstract][Full Text] [Related]
15. Novel staging protocol for non-small-cell lung cancers according to MRP-1/CD9 and KAI1/CD82 gene expression.
Adachi M; Taki T; Konishi T; Huang CI; Higashiyama M; Miyake M
J Clin Oncol; 1998 Apr; 16(4):1397-406. PubMed ID: 9552043
[TBL] [Abstract][Full Text] [Related]
16. CD82/KAI1 inhibits invasion and metastasis of esophageal squamous cell carcinoma via TGF-β1.
Zeng TD; Zheng B; Zheng W; Chen C
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5928-5937. PubMed ID: 30280774
[TBL] [Abstract][Full Text] [Related]
17. Vasculogenic mimicry and aberrant expression of HIF-lα/E-cad are associated with worse prognosis of esophageal squamous cell carcinoma.
Chai DM; Bao ZQ; Hu JG; Ma L; Feng ZZ; Tao YS
J Huazhong Univ Sci Technolog Med Sci; 2013 Jun; 33(3):385-391. PubMed ID: 23771665
[TBL] [Abstract][Full Text] [Related]
18. KAI1/CD82 and cyclin D1 as biomarkers of invasion, metastasis and prognosis of laryngeal squamous cell carcinoma.
Zhang B; Liu W; Li L; Lu J; Liu M; Sun Y; Jin D
Int J Clin Exp Pathol; 2013; 6(6):1060-7. PubMed ID: 23696923
[TBL] [Abstract][Full Text] [Related]
19. HIF-2α not HIF-1α overexpression confers poor prognosis in non-small cell lung cancer.
Gao ZJ; Wang Y; Yuan WD; Yuan JQ; Yuan K
Tumour Biol; 2017 Jun; 39(6):1010428317709637. PubMed ID: 28653893
[TBL] [Abstract][Full Text] [Related]
20. Retinoblastoma binding protein 2 (RBP2) promotes HIF-1α-VEGF-induced angiogenesis of non-small cell lung cancer via the Akt pathway.
Qi L; Zhu F; Li SH; Si LB; Hu LK; Tian H
PLoS One; 2014; 9(8):e106032. PubMed ID: 25162518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
